For breast cancer or malignant melanoma. Sold as Tesuloid, Technecoll, Technetium TC 99M Tsc, An-Sulfur Colloid. Every FDA application for this active ingredient: 4 branded and 1 generic.
As of Nov 22, 2026, FDA lists 5 applications for Technetium TC-99M sulfur colloid kit (sold as Tesuloid, Technecoll, Technetium TC 99M Tsc and others), first approved Jun 10, 1974, with 8 new uses approved and 0 published complete response letters.
| Jun 10, 1974 | TesuloidNDA 16923 · New formulation or manufacturer | Bracco Imaging | 19 | Discontinued |
| Sep 30, 1974 | TechnecollNDA 17059 · New formulation or manufacturer | Mallinckrodt | 8 | Discontinued |
| Nov 18, 1976 | Technetium TC 99M TscNDA 17784 · New formulation or manufacturer | GE Healthcare | 15 | Discontinued |
| Apr 17, 1978 | An-Sulfur ColloidNDA 17858 · New formulation or manufacturer | Sun Pharmaceutical Industries | 26 | Marketed |
| Nov 9, 2023 | Technetium TC-99M Sulfur ColloidANDA 213516 | Jubilant | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA